trial · primary record
Tumor-associated antigen-specific T cell (TAA-T)
Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 14 |
| Primary completion | 2029-10 |
| Primary endpoint | To determine the safety of administering partially HLA-matched TAA-T cells |
| Registry ID | NCT05238792 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:35.777Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05238792
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.